glp-1 market forecast The United States Receptor Agonist Size & Outlook, 2033 GLP-1 Receptor Agonist Market Size
Description
Diabetes remission and relapse after metabolic surgery
The OASIS 1 clinical trial (sponsored by Novo Nordisk) studied oral semaglutide for weight management over 68 weeks
The challenge is that GLP-1 medications suppress thirst for many users
doi: 10.1016/j.jad.2012.10.036 28 CechinS
